Stocks finish mostly lower on Wednesday as 10- through 30-year Treasury yields jump on the risks of inflation.
Latest News
Options markets are bracing for ‘disaster’ as Iran conflict intensifies, Nomura says. Here’s how a trader might profit.
The Iran conflict has sparked tumult in global equity markets, with major indexes in some markets, including South Korea, falling into correction territory.
JPMorgan sees 10% S&P 500 pullback on heightened war concerns
JPMorgan warns S&P 500 traders may be unprepared for a 10% correction as Iran conflict lifts oil above $100; compare Morgan Stanley’s view—read now.
What’s happening with Dow Jones today? Why is Dow down 500 points today – Dow, S&P 500 and Nasdaq fall in deep red
Dow Jones today: The Dow Jones today plunged more than 500 points, sending shockwaves across the U.S. stock market. The Dow Jones Industrial Average
Stock market today: Dow, S&P 500 slip for second day, oil jumps as Iran war rages on
Wall Street continues to be buffeted by the winds of war, as the effects of the Iran war are being seen through widespread volatility.
US Stock Markets Highlights: Dow, S&P 500 fall for second day as oil surge rattles Wall Street
US stock futures edged lower as rising tensions in the Iran war unsettled markets and oil surged, while investors awaited key inflation data for
Stock Market Today: Oil Prices Push Higher Despite IEA Oil Release
Live updates on markets and the top finance, economics and business stories. Plus the latest on the CPI inflation report, oil prices, the Dow,
2 Dow Jones Dividend Stocks to Double Up on and Buy in March
The Dow Jones Industrial Average (^DJI 0.85%) contains 30 industry-leading components — almost all of which pay dividends. These companies act as bellwethers for
Stock Market Live March 11, 2026: S&P 500 (SPY) Flat as Oil Prices Spike Again
Live Updates 2 hours ago Live Shares of HIMS are up another 13%, or by $3.10, on news that Novo Nordisk agreed to distribute
Here's Why Viking Therapeutics Stock Recovered and Can Soar 2026
Key Points A maintenance study could shed light on the tolerability of VK2735’s oral formulation in 2026, ahead of the Phase 3 trial’s conclusion.